Conditions

Scientists believe drug commonly prescribed for T2 could be routinely taken by T1 patients.

Could GLP-1 inhibitors be a useful adjunct therapy in type I diabetes?

In part one of this exclusive interview, Dr. Robert Geho discusses the essential role of the liver in metabolizing insulin, and asks why we hear about the artificial pancreas all the time, but never hear anyone talk about an artificial liver?

In this week's Homerun Slides, ADA guidelines and other special considerations in the treatment of older T2 patients.

Starting patients diagnosed within the last 7 years on 2-4 weeks of intensive insulin therapy could help keep them off additional medications for at least 48 weeks.

Influenza vaccination may reduce cardiac-related hospital admissions and all cause mortality in patients with diabetes.

In this week's Homerun Slides, strategies and new models of care for each of the team members for the purpose of improving outcomes for older T2 patients.

In a controlled trial, 600 overweight and obese people with prediabetes were given metformin.

In this week's Homerun Slides, Dave Joffe, editor-in-chief of Diabetes in Control, presents strategies for helping type 2 patients to achieve their glycemic goals, starting with an outline of diabetes team members.

In this exclusive interview transcript, Dr. Stanley Schwartz discusses the proposed new diabetes classification, which seeks to not only just classify but to help in determining what type of treatment might be best for that patient.